Gastroesophageal reflux disease (GERD) is a common diseases in gastroenterology. With changes in lifestyle, the incidence of this disease is high. The pathogenesis is complex, the disease is protracted and difficult to cure, and the clinical symptoms are complex, which seriously affects the quality of life of patients and brings a great economic burden. At present, the treatment of this disease mainly in-cludes psychological intervention, drug therapy and endoscopic or surgical treatment. This review focuses on the recent research progress on etiology and pathogenesis, diagnosis and treatment from the perspective of Integrated Traditional Chinese and Western Medicine in GERD. 

1.Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease[J]. Gut Liver, 2018, 12(1): 7-16. DOI: 10.5009/gnl16615.

2.Wang K, Zhang L, He ZH, et al. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China[J]. Chin Med J (Engl), 2019, 132(13): 1516-1523. DOI: 10.1097/CM9.0000000000000275.

3.沈小雪, 叶必星, 林琳. 质子泵抑制剂在胃食管反流病合并特发性肺纤维化中的研究进展[J]. 胃肠病学, 2018, 23(9): 573-576. [Shen XX, Ye BX, Lin L. Advances in study on proton pump inhibitor in gastroesophageal re-flux disease combined with idiopathic pulmonary fibrosis[J]. Chinese Journal of Gastroenterology, 2018, 23(9): 573-576.] DOI: 10.3969/j.issn.1008-7125.2018.09. 015.

4.Okereke I, Hamilton C, Wenholz A, et al. Associations of the microbiome and esophageal disease[J]. J Thorac Dis, 2019, 11(Suppl 12): S1588-S1593. DOI: 10.21037/jtd.2019.05.82.

5.刘荣泉, 那吉, 陶家丽,等. 贲门松弛与胃食管反流病患者的食管下段DIS改变[J]. 胃肠病学和肝病学杂志, 2016, 25(1): 62-65. [Liu RQ, Na J, Tao JL, et al. The changes of dilated intercellular space in the esophageal epithelium in patients with patulous cardia and gastroesophageal reflux disease[J]. Chinese Journal of Gastroenterology and Hepatology, 2016, 25(1): 62-65.] DOI: 10.3969/j.issn.1006-5709.2016.01.016.

6.吴丽权, 张亚历,朱薇. 非糜烂性胃食管反流病烧心症状感知机制的认识 [J]. 现代消化及介入诊疗, 2016, 21(4): 667-670. [Wu LQ, Zhang YL, Zhu W. Understanding of the perception mechanism of heartburn symptoms in non-erosive gastroesophageal reflux disease[J]. Modern Digestion & Intervention, 2016, 21(4): 667-670.] DOI: 10.3969/j.issn.1672-2159.2016.04.057.

7.Kim SY, Min C, Park B, et al. Bidirectional association between GERD and rheumatoid arthritis: two longitudinal follow-up studies using a national sample cohort[J]. Clin Rheumatol, 2020, 40(4): 1249-1257. DOI: 10.1007/s100 67-020-05400-0.

8.Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux dis-ease[J]. BMJ, 2020, 371: m3786. DOI: 10.1136/bmj.m3786.

9.Li Y, Fang M, Niu L, et al. Associations among gastroesophageal reflux disease, mental disorders, sleep and chronic temporomandibular disorder: a case-control study[J]. CMAJ, 2019, 191(33): 909-915. DOI: 10.1503/cmaj.181535.

10.周金池,窦维佳,魏延,等.中国胃食管反流病患者焦虑抑郁患病率的Meta分析[J].中国全科医学, 2021, 24(5): 608-613. [Zhou JC, Dou WJ, Wei Y, et al. Anxiety and depression prevalence in Chinese patients with gastroesophageal reflux disease: a meta-analysis[J]. Chinese General Practice, 2021, 24(5): 608-613.] DOI: 10.12114/j.issn.1007-9572.2021.00.080.

11.Shanmugapriya S, Saravanan A, Shuruthi S, et al. Association of gastroesophageal reflux disease with anxiety, depression, and sleep disorders[J]. Journal of Medical Sciences, 2020, 41(1). DOI: 10.4103/jmedsci.jmedsci_51_20.

12.赵新胜, 买买提·依斯热依力, 克力木·阿不都热依木. 非糜烂性食管炎和内脏高敏感研究新进展[J]. 中华胃食管反流病电子杂志, 2019, 6(4): 211-215. [Zhao XS, Yisireyili M, Abudureyimu K. The current resaerch on nonero-sive reflux disease and visceral hypersensitivity[J]. Chinese Journal of Gastroesphageal Reflux Disease (Electronic Edition), 2019, 6(4): 211-215.] DOI: 10.3877/cma.j.issn.2095-8765.2019.04.009.

13.Yucel O. Interactions between helicobacter pylori and gastroesophageal reflux disease[J]. Esophagus, 2019, 16(1): 52-62. DOI: 10.1007/s10388-018-0637-5.

14.Nam SY, Park BJ, Cho YA, et al. Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects[J]. J Gastroenterol, 2017, 52(7): 818-829. DOI: 10.1007/s00535-016-1282-1.

15.郭薇薇, 陈玲, 缪鑫,等. 幽门螺杆菌对胃食管反流病影响的Meta分析[J]. 胃肠病学和肝病学杂志, 2017, 26(10): 1133-1137. [Guo WW, Chen L, Miao X, et al. Association of helicobacter pylori on gastroesophageal reflux disease: a meta-analysis[J]. Chinese Journal of Gastroenterology and Hepatology, 2017, 26(10): 1133-1137.] DOI: 10.3969/j.issn.1006-5709.2017.10.017.

16.刘建东. 根除幽门螺杆菌对慢性萎缩性胃炎患者消化道症状的影响[J]. 中国药物与临床, 2021, 21(4): 663-665. [Liu JD. Effects of helicobacter pylori eradication on gastrointestinal symptoms in patients with chronic atrophic gastritis[J]. Chinese Remedies & Clinics, 2021, 21(4): 663-665.] DOI: 10.11655/zgywylc2021.04.051.

17.中华中医药学会脾胃病分会.胃食管反流病中医诊疗专家共识意见(2017)[J]. 中国中西医结合消化杂志, 2017, 25(5): 321-326. [Branch of Gastrointestinal Disease, China Association of Chinese Medicine. Consensus opin-ions of TCM diagnosis and treatment experts on gastroesophageal reflux disease (2017)[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2017, 25(5): 321-326.] DOI: 10.3969/j.issn.1671-038X.2017.05.01.

18.蓝斯莹, 彭卓嵛, 李桂贤,等. 胃食管反流病中医证候及用药规律文献分析[J]. 世界最新医学信息文摘, 2020, 20(26): 45-47. [Lan SY, Peng ZY, Li GX, et al. Literature analysis on TCM syndrome and drug-use rules in gas-troesophageal reflux disease[J]. World Latest Medicine Information, 2020, 20(26): 45-47.] DOI: 10.3969/j.issn.1671-3141.2020.26.018.

19.马辉, 顾庆华. 顾庆华教授从胆胃论治胃食管反流病经验[J]. 吉林中医药, 2013, 33(2): 122-123. [Ma H, Gu QH. Professor Gu Qinghua's experience in treating gastroesophageal reflux disease from the perspective of gallbladder and stomach[J]. Jilin Journal of Traditional Chinese Medicine, 2013, 33(2): 122-123.] DOI: 10.3969/j.issn.1003-5699.2013.02.007.

20.刘菊, 叶秋荣, 于盼盼. 胃食管反流病中医证型演变规律研究[J]. 山西中医, 2014, 30(5): 45-47. [Liu J, Ye QR, Yu PP. Study on syndromes evolution for gastroesophageal reflux disease[J]. Shanxi Journal of Traditional Chinese Medicine, 2014, 30(5): 45-47.] DOI: 10.3969/j.issn.1000-7156.2014.05.027.

21.王红梅, 张立平, 陈丽如, 等. 基于胃食管反流病的胃肠动力与脾虚实质探究[J]. 中国中西医结合消化杂志, 2015, 23(3): 196-198. [Wang HM, Zhang LP, Chen LR, et al. Gastrointestinal motility and spleen deficiency in gastroesophageal reflux disease[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2015, 23(3): 196-198.] DOI: 10.3969/j.issn.1671-038X. 2015.03.12.

22.沈晨, 陶琳, 张声生, 等. 不同中医证候胃食管反流病患者的食管动力及酸暴露特点研究[J]. 中国中西医结合消化杂志, 2021, 29(9): 605-609. [Shen C, Tao L, Zhang SS, et al. Characteristics of esophageal motility and ac-id exposure in patients with gastroesophageal reflux disease with different Traditional Chinese Medi-cine syndromes[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2021, 29(9): 605-609.] DOI: 10.3969/j.issn.1671-038X.2021.09.02.

23.孙佳琳, 张声生, 朱春洋. 张声生教授从“胃以降为顺”论治胃食管反流病的经验[J]. 天津中医药, 2021, 38(1): 29-33. [Sun JL, Zhang SS, Zhu CY. Professor Zhang Shengsheng's experience in treating gastroesophageal re-flux disease from "declining stomach qi"[J]. Tianjin Journal of Traditional Chinese Medicine, 2021, 38(1): 29-33.] DOI: 10.11656/j.issn.1672-1519.2021.01.07.

24.李科, 李可亮, 杨娟娟,等. 咽喉反流性疾病诊断和治疗研究进展[J]. 中国中西医结合耳鼻咽喉科杂志, 2020, 28(2): 157-160. [Li K, Li KL, Yang JJ, et al. Progress in diagnosis and treatment of laryngopharyngeal reflux disease[J]. Chinese Journal of Otorhinolaryngology in Integrative Medicine, 2020, 28(2): 157-160.] DOI: 10.16542/j.cnki.issn.1007-4856.2020.02.022.

25.孙旭彤, 姜顺顺, 续婷婷,等. 蓝激光放大内镜在非糜烂性反流病诊断中的作用[J]. 临床消化病杂志, 2020, 32(1): 5-8. [Sun XT, Jiang SS, Xu TT, at al. The role of blue laser magnifying endoscopy in the diagnosis of non-erosive reflux disease[J]. Chinese Journal of Clinical Gastroenterology, 2020, 32(1): 5-8.] DOI: 10.3870/lcxh.j.issn.1005-541X.2020.01.002.

26.Dağlı Ü, Kalkan İH. The role of lifestyle changes in gastroesophageal reflux diseases treatment[J]. Turk J Gastroenterol, 2017, 28(Suppl 1): S33-S37. DOI: 10.5152/tjg. 2017.10. 

27.中华医学会消化病学分会. 2014年中国胃食管反流病专家共识意见[J]. 中华消化杂志, 2014, 34(10): 649-661. [Branch of Gastroenterology, Chinese Medical Association. Expert consensus on reflux disease in China in 2014[J]. Chinese Journal of Digestion, 2014, 34(10): 649-661.] DOI: 10.3760/cma.j.issn.0254-1432.2014.10.001.

28.Tommasi S, Elliot DJ, Hulin JA, et al. Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance[J]. Sci Rep, 2017, 7(1): 2871. DOI: 10.1038/s41598-017-03069-1.

29.Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors[J]. Gut, 2012, 61(9): 1340-1354. DOI: 10.1136/gutjnl-2011-301897.

30.Chen J, Brady P. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment[J]. Gas-troenterol Nurs, 2019, 42(1): 20-28. DOI: 10.1097/SGA.00000000 00000359.

31.Sowa P, Samarasena JB. Nonablative radiofrequency treatment for gastroesophageal reflux disease (STRETTA)[J]. Gastrointest Endosc Clin N Am, 2020, 30(2): 253-265. DOI: 10.1016/j.giec.2019.12.006.

32.Kagami T, Yamade M, Suzuki T, et al. Comparative study of effects of vonoprazan and esomeprazole on antiplatelet function of clopidogrel or prasugrel in relation to CYP2C19 genotype[J]. Clin Pharmacol Ther, 2018, 103(5): 906-913. DOI: 10.1002/cpt.863.

33.Akiyama J, Hosaka H, Kuribayashi S, et al. Efficacy of Vonoprazan, a novel potassium-competitive acid blocker, in patients with proton pump inhibitor-refractory acid reflux[J]. Digestion, 2020, 101(2): 174-183. DOI: 10.1159/000497775.

34.Shaheen NJ, Adler J, Dedrie S, et al. Randomised clinical trial: the 5-HT4 agonist revexepride in pa-tients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy[J]. Aliment Pharmacol Ther, 2015, 41(7): 649-661. DOI: 10.1111/apt.13115.

35.褚源, 胡焕标, 吴凯,等. 胃食管反流病患者精神心理因素、生活质量、睡眠质量的分析以及联用黛力新治疗的疗效观察[J]. 现代消化及介入诊疗, 2019, 24(10): 1095-1099. [Chu Y, Hu HB, Wu K, et al. Analysis of mental and psychological factors，quality of life，sleep quality in patients with gastroesophageal reflux disease and the efficacy of combined treatment with Deanxit[J]. Modern Digestion ＆ Intervention, 2019, 24(10): 1095-1099.] DOI: 10.3969/j.issn.1672-2159.2019.10.005.

36.李浩, 魏良洲. 抗抑郁药治疗难治性胃食管反流病的研究进展[J]. 中华消化杂志, 2019, 39(11): 791-792. [Li H, Wei LZ. Research progress in the treatment of refractory gastroesophageal reflux disease with antide-pressants[J]. Chinese Journal of Digestion, 2019, 39(11): 791-792.] DOI: 10.3760/cma.j.issn.0254-1432.2019.11.016.

37.胡海清, 柴宁莉, 令狐恩强, 等. 经口内镜下贲门缩窄术治疗胃食管反流病的临床研究[J]. 中华胃肠内镜电子杂志, 2016, 3(2): 65-67. [Hu HQ, Chai NL, Linghu EQ, et al. Peroral endoscopic cardial constriction (PECC) in gastroesophageal reflux disease[J]. Chinese Journal of Gastrointestinal Endoscopy (Electronic Edition), 2016, 3(2): 65-67.] DOI: 10.3877/cma.j.issn.2095-7157.2016. 02.004.

38.贾宁, 唐艳萍, 李杨. 现代医学对胃食管反流病研究机制进展[J]. 中国中西医结合外科杂志, 2020, 26(1): 179-183. [Jia N, Tang YP, Li Y. Progress in the research mechanism of gastroesophageal reflux disease in mod-ern medicine[J]. Chinese Journal of Surgery of Integrated Traditional and Western Medicine, 2020, 26(1): 179-183.] DOI: 10.3969/j.issn.1007-6948.2020.01.038.

39.Rodríguez L, Rodriguez PA, Gómez B, et al. Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results[J]. Surg Endosc, 2016, 30(7): 2666-2672. DOI: 10.1007/s00464-015-4539-5.

40.孙萍胡, 王维红, 包震飞, 等. 内镜下抗反流黏膜切除术治疗难治性胃食管反流病初探[J]. 中国内镜杂志, 2020, 26(7): 20-24. [Sun PH, Wang WH, Bao ZF, et al. Preliminary results of anti-reflux mucosectomy in treatment of refractory gastroesophageal reflux disease[J].  China Journal of Endoscopy, 2020, 26(7): 20-24.] DOI: 10.3969/j.issn.1007-1989.2020.07.004.

41.中华中医药学会脾胃病分会. 胃食管反流病中医诊疗专家共识意见(2017年)[J]. 中国中西医结合消化杂志, 2017, 25(5): 321-326. [Spleen and Stomach Diseases Branch of China Association of Traditional Chinese Medicine. Consensus opinions of TCM diagnosis and treatment experts on gastroesophageal reflux disease (2017)[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2017, 25(5): 321-326.] DOI: 10.13288/j.11-2166/r.2017.13.023.

42.周佩琳, 刘万里, 杨璐, 等. 难治性胃食管反流病中医药研究进展[J]. 辽宁中医药大学学报, 2020, 22(8): 217-220. [Zhou PL, Liu WL, Yang L, et al. Research progress of Traditional Chinese Medicine in refractory gas-troesophageal reflux disease[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2020, 22(8): 217-220.] DOI: 10.13194/j.issn.1673-842x.2020.08.054.

43.王高峰, 朱生樑. 朱生樑辨治难治性胃食管反流病经验撷英[J]. 上海中医药杂志, 2020, 54(1): 30-32. [Wang GF, Zhu SL. Zhu Shengliang's experience in treatment of refractory gastroesophageal reflux disease[J]. Shanghai Journal of Traditional Chinese Medicine, 2020, 54(1): 30-32.] DOI: 10.16305/j.1007-1334.2020.01.007. 

44.程艳梅, 王倩影. 疏肝和胃方治疗非糜烂性胃食管反流病疗效观察及对患者焦虑、抑郁状态的影响[J]. 上海中医药杂志, 2021, 55(4): 63-65. [Chen YM, Wang QY. Therapeutic effect of Shugan Hewei decoction in treatment of non-erosive gastroesophageal reflux and its effect on anxiety and depression[J]. Shanghai Journal of Traditional Chinese Medicine, 2021, 55(4): 63-65.] DOI: 10.16305/j. 1007-1334.2021.2012066.

45.雷红玮, 张慧, 李聚林. 柴胡疏肝散对非糜烂性反流病肝胃不和证食管内脏高敏感性外周敏化机制的影响[J]. 山西中医药大学学报, 2019, 20(6): 452-454. [Lei HW, Zhang H, Li JL. Effect of Chaihu Shugan powder for non-erosive reflux disease patients with liver-stomach disharmony syndrome peripheral sensitization on esophageal visceral hypersensitivity[J]. Journal of Shanxi university of Chinese Medicine, 2019, 20(6): 452-454.] DOI: 10.19763/j.cnki.2096-7403.2019.06.21.

46.李海丹, 周志伟, 黄欢龙. 半夏泻心汤治疗返流性食管炎的临床观察[J]. 深圳中西医结合杂志, 2021, 31(7): 61-62. [Li HD, Zhou ZW, Huang HL. Clinical observation on Banxia Xiexin decoction for reflux esophagitis[J]. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 2021, 31(7): 61-62.] DOI: 10.16458/j.cnki.1007-0893.2021.07.029.

47.黄河. 大柴胡汤合左金丸加减治疗胃食管反流病疗效观察[J]. 国医论坛, 2021, 36(5): 34-35. [Huang H. Observa-tion on the curative effect of Dachaihu decoction and Zuojin pill in treating gastroesophageal reflux disease[J]. Forum on Traditional Chinese Medicine, 2021, 36(5): 34-35.] DOI: 10.13913/j.cnki.41-1110/r.2021.05.015.

48.唐丽明, 宋宁, 熊鹰, 等. 旋覆代赭汤加味治疗肝胃不和型难治性胃食管反流病的临床疗效及对胃肠激素的影响[J]. 辽宁中医杂志, 2020, 47(11): 109-112. [Tang LM, Song N, Xiong Y, et al. Effect of modified Xuanfu Daizhe decoction on refractory gastroesophageal reflux disease of disharmony between liver and stomach syndrome and its influence on gastrointestinal hormones[J]. Liaoning Journal of Traditional Chinese Medicine, 2020, 47(11): 109-112.] DOI: 10.13192/j.issn.1000-1719.2020.11.032.

49.梁军, 喻晓刚, 杨燕. 加味柴胡疏肝散联合奥美拉唑和莫沙必利治疗胃食管反流病的临床疗效观察[J]. 四川中医, 2014, 32(7): 93-95. [Liang J, Yu XG, Yang Y. Clinical observation of using modified Chaihu Shugan powder com-bined with omeprazole and mosapride to treat gastroesophageal reflux disease[J]. Journal of Sichuan of Traditional Chinese Medicine, 2014, 32(7): 93-95.] DOI: CNKI:SUN:SCZY.0.2014-07-045.

50.胡云歌, 王静, 杨强. 蒿芩清胆汤联合雷贝拉唑治疗胆热犯胃型胃食管反流病32例[J].湖南中医杂志, 2020, 36(9): 47-49. [Hu YG, Wang J, Yang Q. Treatment of 32 cases of gastroesophageal reflux disease caused by bile fever with Haoqin Qingdan decoction combined with rabeprazole[J]. Hunan Journal of Traditional Chinese Medicine, 2020, 36(9): 47-49.] DOI: 10.16808/j.cnki.issn1003-7705.2020.09.019.

51.李青松, 王志敏, 刘跃平,等. 左金丸合化肝煎加减治疗胃食管反流病肝胃郁热证临床研究[J]. 新中医, 2019, 51(4): 97-99. [Li QS, Wang ZM, Liu YP, et al. Clinical study on Zuojin pills combined with modified Huagan Jian for gastroesophageal reflux disease with liver-stomach heat stagnation syndrome[J]. Journal of New Chinese Medicine, 2019, 51(4): 97-99.] DOI: 10.13457/j.cnki.jncm.2019.04.031.

52.张雷永. 四逆温胆汤加味联合雷贝拉唑治疗胃食管反流病47例疗效观察[J]. 国医论坛, 2018, 33(5): 45-47. [Zhang LY. Clinical observation on 47 cases of gastroesophageal reflux disease treated with Siwen Dan de-coction combined with rabeprazole[J]. Forum on Traditional Chinese Medicine, 2018, 33(5): 45-47.] DOI: CNKI:SUN:GYLT.0.2018-05-022.

53.肖茹萍, 姜礼双, 崔亚, 等. 难治性胃食管反流病脾虚证CYP2C19基因表达及中药干预研究[J]. 中国中西医结合杂志, 2018, 38(1): 25-28. [Xiao RP, Jiang LS, Cui Y, et al. CYP2C19 gene expression of refractory gas-troesophageal reflux disease patients with pi deficiency syndrome and intervention of Chinese herbs[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2018, 38(1): 25-28.] DOI: 10.7661/j.cjim.20171207.453.

54.尹毅, 朱存成. 柴胡温胆汤联合西药对非糜烂性胃食管反流病合并焦虑抑郁的疗效及对自主神经功能影响[J]. 辽宁中医杂志, 2020, 47(8): 97-99. [Yin Y, Zhu CC. Effect of Chaihu Wendan decoction combined with western medicine on non-erosive gastroesophageal reflux disease combined with anxiety depression and its effect on autonomic nerve function[J]. Liaoning Journal of Traditional Chinese Medicine, 2020, 47(8): 97-99.] DOI: 10.13192/j.issn.1000-1719.2020.08.028.

55.王劲松. 疏肝和胃法联合氟哌噻吨美利曲辛治疗非糜烂性胃食管反流病伴抑郁45例[J]. 环球中医药, 2019, 12(1): 95-97. [Wang JS. Treatment of 45 cases of non-erosive gastroesophageal reflux disease with depres-sion by liver-relieving and stomach-relieving method combined with flupentixol melitracine[J]. Global Traditional Chinese Medicine, 2019, 12(1): 95-97.] DOI: 10.3969/j.issn.1674-1749.2019.01.030.

56.涂焱华, 袁朵. 平冲降逆汤结合体表穴位电刺激治疗难治性胃食管反流病临床疗效及安全性观察[J]. 四川中医, 2021, 39(5): 96-99. [Tu YH, Yuan D. Pingchong Jiangni decoction combined with body surface acupoint electrical stimula-tion is difficult to treat clinical efficacy and safety of gastroesophageal reflux disease[J]. Journal of Si-chuan of Traditional Chinese Medicine, 2021, 39(5): 96-99.] DOI: CNKI:SUN:SCZY.0.2021-05-029.

57.刘晓华. 针刺机理及其哲学基础[J].世界中西医结合杂志, 2017, 12(6): 744-748. [Liu XH. Acupuncture mecha-nism and its philosophic foundation[J]. World Journal of Integrated Traditional and Western Medicine, 2017, 12(6): 744-748.] DOI: 10.13935/j.cnki.sjzx.170602.

58.黄雪, 白兴华, 刘镇文, 等. 针刺督脉背段T3~T12棘突下治疗难治性胃食管反流病的临床观察[J]. 上海中医药杂志, 2019, 53(2): 64-67. [Huang X, Bai XH, Liu ZW, et al. Clinical observation on acupuncture treatment of refractory gastroesophageal reflux disease by needling dorsal segment of governor vessel below spinous processes from T3 to T12[J]. Shanghai Journal of Traditional Chinese Medicine, 2019, 53(2): 64-67.] DOI: 10.16305/j.1007-1334.2019.02.017.

59.贾剑南, 唐艳萍, 刘茜. 活血通降方合并针灸治疗难治性反流性食管炎瘀血阻络型63例临床研究[J]. 中国中西医结合消化杂志, 2019, 27(7): 485-490. [Jia JN, Tang YP, Liu Q. Clinical study on 63 cases of refractory reflux esophagitis with bloodstasis and collateral obstruction treated by Huoxue Tongjiang decoction com-bined with acupuncture and moxibustion[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2019, 27(7): 485-490.] DOI: 10.3969/j.issn.1671-038X.2019.07.02.

60.张潇斌, 王凤笑, 姜程洋, 等. 针刺“鼻胃”穴配合隔药灸脐法治疗反流性食管炎26例[J]. 中国针灸, 2020, 40(3): 277-278. [Zhang XB, Wang FX, Jiang CY, et al. Treatment of 26 cases of reflux esophagitis by acu-puncturing nasogastric point and moxibustion umbilicus by separating medicine[J]. Chinese Acupunc-ture & Moxibustion, 2020, 40(3): 277-278.] DOI: 10.13703/j.0255-2930.20190919-k0002.

61.安彬, 陈振东, 张洪涛. 针刺治疗胃食管反流病研究进展[J]. 中医研究, 2020, 33(11): 74-77. [An B, Chen ZD, Zhang HT. Research progress of acupuncture in the treatment of gastroesophageal reflux disease[J]. Traditional Chinese Medicinal Research, 2020, 33(11): 74-77.] DOI: 10.3969/j.issn.1001-6910.2020.11.25.

62.何婧, 王毅, 周竞, 等. 艾司奥美拉唑联合穴位针灸治疗中虚气逆型胃食管反流病的临床观察[J]. 世界中西医结合杂志, 2021, 16(6): 1079-1083, 1088. [He J, Wang Y, Zhou J, et al. Clinical observation of esomeprazole combined with acupoint acupuncture in treating gastroesophageal reflux disease of deficiency of Qi and Inversion[J]. World Journal of Integrated Traditional and Western Medicine, 2021, 16(6): 1079-1083, 1088.] DOI: 10.13935/j.cnki.sjzx.210619.

63.中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663. [Branch of Gastroenterology, Chinese Medical  Association. Chinese expert consensus on gatroesophageal reflux disease in 2020[J]. Chinese Journal of Digestion, 2020, 40(10): 649-663.] DOI: 10.3760/cma.j.cn311367-20200918-00558.